Can any of the more knowledgeable posters give us a simple basic explanation of Leronlimab's Method of Action in NASH. It's probably been discussed previously, but I missed it or just don't remember. Seems a good time for it now. TIA, Ganesha

Later edit: When I wrote this I hadn't seen Ohm's post #112327 which seems to fill the bill. As always, thanks for your help.